NGT HealthCare II
Overview
NGT HealthCare II is an impact venture capital fund that invests in early-stage companies in the fields of biotechnology, bio-convergence, and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| IntraGel Therapeutics | Aug 2023 | Seed | Co-investor |
| Dio Tree | Dec 2022 | Seed | Co-investor |
| Ark Surgical | Jun 2021 | VC Round | Co-investor |
| CardioVia | Apr 2018 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Evan Renov
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NGT HealthCare II based?
NGT HealthCare II is headquartered in Nazareth, Israel.
When was NGT HealthCare II founded?
NGT HealthCare II was founded in 2021.
How many portfolio companies does NGT HealthCare II have?
NGT HealthCare II has 6 portfolio companies in Caplight's dataset.
What are some companies in NGT HealthCare II's portfolio?
Recent investments visible on Caplight include IntraGel Therapeutics, IntraGel Therapeutics, Dio Tree, Ark Surgical, CardioVia.
What was NGT HealthCare II's most recent investment?
NGT HealthCare II's most recent investment on Caplight was in IntraGel Therapeutics in 2023.
What sectors does NGT HealthCare II focus on?
NGT HealthCare II focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce.
What company stages does NGT HealthCare II focus on?
NGT HealthCare II typically invests at the Early stage.
What is NGT HealthCare II's AUM?
NGT HealthCare II's assets under management are estimated between $92.0M and $122.0M.